EUVIMEDAtrasti EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Update on vascular control of central chemoreceptors

Thiago S Moreira iD, Daniel K Mulkey, Ana C Takakura iD

Experimental Physiology · 2024

DOI: 10.1113/ep091329 ↗

At a glance

Übersichtsarbeit in Experimental Physiology, 2024. Written by Thiago S Moreira and 2 co-authors. Institution: Department of Physiology and Biophysics, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, Brazil. Major MEDLINE topics: Chemoreceptor Cells, Carbon Dioxide. Cited 4 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY 4.0). Funded by: NINDS NIH HHS, NHLBI NIH HHS, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

At least four mechanisms have been proposed to elucidate how neurons in the retrotrapezoid (RTN) region sense changes in CO 2 /H + to regulate breathing (i.e., function as respiratory chemosensors). These mechanisms include: (1) intrinsic neuronal sensitivity to H + mediated by TASK‐2 and GPR4; (2) paracrine activation of RTN neurons by CO 2 ‐responsive astrocytes (via a purinergic mechanism); (3) enhanced excitatory synaptic input or disinhibition; and (4) CO 2 ‐induced vascular contraction. Although blood flow can influence tissue CO 2 /H + levels, there is limited understanding of how control of vascular tone in central CO 2 chemosensitive regions might contribute to respiratory output. In this review, we focus on recent evidence that CO 2 /H + ‐induced purinergic‐dependent vasoconstriction in the ventral parafacial region near RTN neurons supports respiratory chemoreception. This mechanism appears to be unique to the ventral parafacial region and opposite to other brain regions, including medullary chemosensor regions, where CO 2 /H + elicits vasodilatation. We speculate that this mechanism helps to maintain CO 2 /H + levels in the vicinity of RTN neurons, thereby maintaining the drive to breathe. Important next steps include determining whether disruption of CO 2 /H + vascular reactivity contributes to or can be targeted to improve breathing problems in disease states, such as Parkinson's disease.

Subjects

MeSH terms (MEDLINE)

Chemoreceptor CellsCarbon DioxideAnimalsHumansNeuronsVasoconstrictionRespirationVasodilation

Author keywords

Parkinson's diseasebreathingchemoreflexpurinergic signallingretrotrapezoid nucleus

Substances

Carbon Dioxide

Authors and institutions

  • Department of Physiology and Biophysics, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Department of Physiology and Neurobiology, University of Connecticut, Storrs, Connecticut, USA.
  • Department of Pharmacology, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, São Paulo, Brazil.

ORCID profiles: Thiago S Moreira, Ana C Takakura

Funding

  • NINDS NIH HHS
  • NHLBI NIH HHS
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • National Heart, Lung, and Blood Institute

Cite

APA

Moreira, T. S., Mulkey, D. K., & Takakura, A. C. (2024). Update on vascular control of central chemoreceptors. Experimental Physiology. https://doi.org/10.1113/ep091329

Vancouver

Moreira TS, Mulkey DK, Takakura AC. Update on vascular control of central chemoreceptors. Experimental Physiology. 2024. doi:10.1113/ep091329

BibTeX
@article{Moreira2024,
  author = {Moreira, Thiago S and Mulkey, Daniel K and Takakura, Ana C},
  title = {Update on vascular control of central chemoreceptors},
  journal = {Experimental Physiology},
  year = {2024},
  doi = {10.1113/ep091329}
}
Start for free →